We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLAB icon
976
Silicon Laboratories
SLAB
$7.17B
– –
-1,877
Closed -$246K
SLNO
977
DELISTED
Soleno Therapeutics
SLNO
– –
-4,257
Closed -$288K
SLP icon
978
Simulations Plus
SLP
$371M
– –
-10,313
Closed -$155K
SMBC icon
979
Southern Missouri Bancorp
SMBC
$854M
– –
-7,548
Closed -$397K
SNBR
980
DELISTED
Sleep Number
SNBR
– –
-18,914
Closed -$133K
SNDR icon
981
Schneider National
SNDR
$6.44B
– –
-20,716
Closed -$438K
SNOW icon
982
Snowflake
SNOW
$94.6B
– –
-940
Closed -$212K
SON icon
983
Sonoco
SON
$5.8B
– –
-7,944
Closed -$342K
SPCE icon
984
Virgin Galactic
SPCE
$325M
– –
-11,066
Closed -$42.7K
SPT icon
985
Sprout Social
SPT
$500M
– –
-22,598
Closed -$292K
SRCE icon
986
1st Source
SRCE
$2.09B
– –
-3,679
Closed -$226K
SRI icon
987
Stoneridge
SRI
$210M
– –
-39,787
Closed -$303K
SRPT icon
988
Sarepta Therapeutics
SRPT
$1.68B
– –
-18,523
Closed -$357K
STEP icon
989
StepStone Group
STEP
$3.65B
– –
-3,097
Closed -$202K
STNG icon
990
Scorpio Tankers
STNG
$3.9B
– –
-5,685
Closed -$319K
SXT icon
991
Sensient Technologies
SXT
$5.32B
– –
-3,242
Closed -$304K
SYF icon
992
Synchrony
SYF
$24.5B
– –
-3,585
Closed -$255K
TBPH icon
993
Theravance Biopharma
TBPH
$874M
– –
-10,751
Closed -$157K
TCBI icon
994
Texas Capital Bancshares
TCBI
$4.28B
– –
-4,470
Closed -$378K
TCMD icon
995
Tactile Systems Technology
TCMD
$626M
– –
-12,756
Closed -$177K
TFPM icon
996
Triple Flag Precious Metals
TFPM
$6B
– –
-6,879
Closed -$201K
TKNO icon
997
Alpha Teknova
TKNO
$260M
– –
-37,645
Closed -$233K
TMDX icon
998
Transmedics
TMDX
$2.57B
– –
-3,841
Closed -$431K
TME icon
999
Tencent Music
TME
$15.3B
– –
-14,396
Closed -$336K
TMO icon
1000
Thermo Fisher Scientific
TMO
$208B
– –
-744
Closed -$361K
38 39
40
41 42

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.